Comparison of inflammation-related hematologic indices for predicting metabolic syndrome in adults

ArticleAçık Erişim

Özet

Aim: It was planned to evaluate different hematologic indices (neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), lymphocyte/high-density lipoprotein to cholesterol ratio (LHR), neutrophil/high-density lipoprotein to cholesterol ratio (NHR), and monocyte/high-density lipoprotein to cholesterol ratio (MHR)) associated with inflammation in predicting metabolic syndrome in adults and to predict which marker is the better predictor. Materials and methods: This study comprised 399 adults between the ages of 18 and 65. Bodyweight, height, waist circumference, and blood pressure were measured; fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, and hemogram values were analyzed. The International Diabetes Federation criteria were used to define metabolic syndrome. Results: The study included 133 (33.3%) males and 266 (66.4%) females with an average age of 54.3 ± 11.8 years. The prevalence of metabolic syndrome is 58.6% (male 44.3%; female 65.7%). For both men (AUC = 0.730, cutoff = 4.5) and women (AUC = 0.669, cutoff = 4.2), the NHR index has the highest AUC. LHR has the second-highest metabolic syndrome determination in men (AUC = 0.647, cutoff = 6.9). Women’s LHR (AUC = 0.626, cutoff = 6.4) and LMR (AUC = 0.757, cutoff = 4.9) had the second and third highest AUCs, respectively, while NLR and PLR were not significant in either gender (p > 0.05). Conclusion: The NHR index is a strong predictor of metabolic syndrome. In men, the NHR index is a better predictor of metabolic syndrome than the LHR index, and in women, the NHR index is better than the LHR and LMR. © 2022, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12479Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s13410-022-01093-0Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYilmaz, Sevil Karahan
dc.contributor.authorÖzçiçek, Fatih
dc.date.accessioned2026-10-18T20:27:22.688177767Z
dc.date.available2026-10-18T20:27:22.688177767Z
dc.date.issued2023
dc.description.abstractAim: It was planned to evaluate different hematologic indices (neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), lymphocyte/high-density lipoprotein to cholesterol ratio (LHR), neutrophil/high-density lipoprotein to cholesterol ratio (NHR), and monocyte/high-density lipoprotein to cholesterol ratio (MHR)) associated with inflammation in predicting metabolic syndrome in adults and to predict which marker is the better predictor. Materials and methods: This study comprised 399 adults between the ages of 18 and 65. Bodyweight, height, waist circumference, and blood pressure were measured; fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, and hemogram values were analyzed. The International Diabetes Federation criteria were used to define metabolic syndrome. Results: The study included 133 (33.3%) males and 266 (66.4%) females with an average age of 54.3 ± 11.8 years. The prevalence of metabolic syndrome is 58.6% (male 44.3%; female 65.7%). For both men (AUC = 0.730, cutoff = 4.5) and women (AUC = 0.669, cutoff = 4.2), the NHR index has the highest AUC. LHR has the second-highest metabolic syndrome determination in men (AUC = 0.647, cutoff = 6.9). Women’s LHR (AUC = 0.626, cutoff = 6.4) and LMR (AUC = 0.757, cutoff = 4.9) had the second and third highest AUCs, respectively, while NLR and PLR were not significant in either gender (p > 0.05). Conclusion: The NHR index is a strong predictor of metabolic syndrome. In men, the NHR index is a better predictor of metabolic syndrome than the LHR index, and in women, the NHR index is better than the LHR and LMR. © 2022, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India.
dc.identifier.doi10.1007/s13410-022-01093-0
dc.identifier.eissn1998-3832
dc.identifier.endpage190
dc.identifier.issn0973-3930
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85131589387
dc.identifier.startpage184
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12479
dc.identifier.volume43
dc.identifier.wosWOS:000807276200001
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofInternational Journal of Diabetes in Developing Countries
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLymphocyte/high-density lipoprotein to cholesterol ratio
dc.subjectLymphocyte/monocyte ratio
dc.subjectMetabolic syndrome
dc.subjectMonocyte/high-density lipoprotein to cholesterol ratio
dc.subjectNeutrophil/high-density lipoprotein to cholesterol ratio
dc.subjectC reactive protein
dc.subjectcholesterol
dc.subjecthigh density lipoprotein cholesterol
dc.subjectlow density lipoprotein cholesterol
dc.subjecttriacylglycerol
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectblood pressure monitoring
dc.subjectbody height
dc.subjectbody weight
dc.subjectcholesterol blood level
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectcorrelational study
dc.subjectcross-sectional study
dc.subjectfemale
dc.subjectgender
dc.subjectglucose blood level
dc.subjecthuman
dc.subjectInternational Diabetes Federation
dc.subjectlymphocyte monocyte ratio
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmetabolic syndrome X
dc.titleComparison of inflammation-related hematologic indices for predicting metabolic syndrome in adults
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.citation.wos3
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)